Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127010631 | 12701063 | 1 | I | 20160826 | 0 | 20160830 | 20160830 | DIR | 58.00 | YR | F | N | 150.00000 | LBS | 20160829 | N | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127010631 | 12701063 | 1 | PS | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | Oral | 1 CAPSULE(S) THREE TIMES A DAY TAKEN BY MOUTH | N | D | 0 | 1 | DF | CAPSULE | TID | ||||
127010631 | 12701063 | 3 | C | VALIUM | DIAZEPAM | 1 | 0 | ||||||||||||
127010631 | 12701063 | 5 | C | ALLERGY SHOTS | UNSPECIFIED INGREDIENT | 1 | 0 | ||||||||||||
127010631 | 12701063 | 7 | C | ADVIL | IBUPROFEN | 1 | 0 | ||||||||||||
127010631 | 12701063 | 9 | C | ESSENTIAL HOLISTIC OILS | 2 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127010631 | 12701063 | 1 | Clostridium difficile infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127010631 | 12701063 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127010631 | 12701063 | Foot fracture | |
127010631 | 12701063 | Hypoaesthesia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127010631 | 12701063 | 1 | 2 | DAY |